Log in  First Connection?

Dialysis: Archives News of the month

Real-world use of difelikefalin in hemodialysis patients at a large dialysis organization in the United States: a retrospective database study
Dialysis
 5 min.

 Published on 02/04/2025 |  Original article (Abstract)  | Ficociello Linda H. et al. | BMC Nephrology 2025; 26(1): 156

Chronic kidney disease–associated pruritus (CKD-aP), previously referred to as uremic pruritus, is itching due to kidney disease that can vary in clinical presentation from mild to severe and can affect patient quality of life and survival [1, 2–3]. CKD-aP can be recurrent and sometimes persistent...

Association of the remnant cholesterol to high-density lipoprotein cholesterol ratio with mortality in peritoneal dialysis patients
Dialysis
 5 min.

 Published on 26/03/2025 |  Original article (Abstract)  | Wang Zebin et al. | Lipids in Health and Disease 2025; 24(1): 107

End-stage renal illness severely affects health care systems and is prevalent worldwide [1]. One of the primary options for end-stage renal illness, which affects approximately 11% of dialysis patients overall, is continuous ambulatory peritoneal dialysis (CAPD) [2]. Cardiovascular complications represent...

The association between the atherogenic index of plasma and all-cause mortality in patients undergoing peritoneal dialysis: a multicenter cohort study
Dialysis
 4 min.

 Published on 19/03/2025 |  Original article (Abstract)  | Hu Yaohua et al. | Lipids in Health and Disease 2025; 24(1): 91

End-stage kidney disease (ESKD) is a critical global health issue, imposing a significant burden on healthcare systems [1, 2]. From 2000 to 2019, the prevalence rate of ESKD among Asians increased by 149.5% [3]. Hemodialysis (HD) and peritoneal dialysis (PD) are the two primary treatment modalities for...

The impact of low-protein diet on residual renal function in dialysis patients: a systematic review and metaanalysis
Dialysis
 4 min.

 Published on 12/03/2025 |  Original article (Abstract)  | Xie Jingyi et al. | BMC Nephrology 2025; 26(1): 122

As a significant global public health issue, chronic kidney disease (CKD) affects millions of people worldwide [1, 2]. The progression of CKD can result in a gradual deterioration of renal function and ultimately come to end-stage renal disease (ESKD), requiring life-sustaining peritoneal dialysis or...

Design and psychometric validation of a social capital questionnaire for adults with end-stage chronic kidney disease undergoing dialysis or hemodialysis
Dialysis
 7 min.

 Published on 05/03/2025 |  Original article (Abstract)  | Alanis-Ocádiz Alicia et al. | BMC Nephrology 2025; 26(1): 105

Chronic Kidney Disease (CKD) is a worldwide public health problem that has become a leading cause of death, with an estimated prevalence of 9.1% [1]. The global incidence of end-stage kidney disease (ESKD) is 146 individuals per million population (pmp) per year. The highest incidence of ESKD can be...